Methylprednisolone for Acute Asthma Exacerbation
For acute asthma exacerbations, administer methylprednisolone 40-80 mg daily (or equivalent oral prednisolone 30-60 mg daily) until peak expiratory flow reaches 70% of predicted or personal best, typically for 5-10 days without tapering. 1, 2
Route of Administration
Oral corticosteroids are equally effective as intravenous therapy and should be used first-line unless the patient is vomiting, severely ill, or unable to tolerate oral medications. 1, 2
- Oral route: Prednisolone 30-60 mg daily is preferred for all patients who can tolerate oral intake 3, 2
- Intravenous route: Use IV hydrocortisone 200 mg immediately, then 200 mg every 6 hours OR methylprednisolone 125 mg (dose range 40-250 mg) if patient cannot take oral medications 3, 1, 2
- Research confirms no advantage of IV over oral administration when gastrointestinal absorption is intact 4, 5
Dosing by Severity
Moderate Exacerbation (PEF 40-69%, can complete sentences, pulse <110, RR <25)
- Oral prednisolone 30-60 mg daily for 5-10 days 3, 2
- Methylprednisolone equivalent: 40-80 mg daily 1, 2
Severe Exacerbation (PEF <50%, cannot complete sentences, pulse >110, RR >25)
- Oral prednisolone 40-80 mg daily OR IV hydrocortisone 200 mg immediately, then 200 mg every 6 hours 3, 2
- Methylprednisolone equivalent: 125 mg IV initially 1, 6
- Reassess response at 15-30 minutes after initial bronchodilator treatment 3, 2
Life-Threatening Features (PEF <33%, silent chest, confusion, exhaustion, cyanosis)
- IV hydrocortisone 200 mg immediately, then 200 mg every 6 hours 3, 2
- Consider ICU transfer if deteriorating despite treatment 3
Pediatric Dosing
- Oral prednisolone 1-2 mg/kg/day in 2 divided doses (maximum 60 mg/day) for 3-10 days 3, 2
- Calculate dose based on ideal body weight in overweight children to avoid excessive steroid exposure 2
- IV hydrocortisone 4 mg/kg as initial dose if unable to tolerate oral intake 2
Duration and Tapering
- Continue treatment for 5-10 days for outpatient management until PEF reaches ≥70% of predicted or personal best 1, 2
- No tapering is necessary for courses lasting less than 7-10 days, especially if patient is concurrently taking inhaled corticosteroids 1, 2
- For severe cases requiring hospitalization, 7 days is often sufficient, but may extend up to 21 days until lung function returns to baseline 2
Concurrent Essential Therapy
- Nebulized salbutamol 5 mg (or terbutaline 10 mg) every 4 hours initially, increasing to every 30 minutes if not improving 3
- Oxygen 40-60% to maintain SpO2 >92% 3, 2
- Add ipratropium 0.5 mg to nebulizer if patient not improving after 15-30 minutes, repeat every 6 hours 3
Critical Timing Considerations
Administer systemic corticosteroids within 1 hour of presentation for all moderate-to-severe exacerbations, as anti-inflammatory effects take 6-12 hours to become apparent 1, 2
Evidence Quality Note
Higher doses of corticosteroids (>360 mg methylprednisolone equivalent per 24 hours) have not shown additional benefit over lower doses (≤80 mg) in multiple randomized controlled trials 7, 5. The recommended dosing range of 40-80 mg daily represents the optimal balance between efficacy and minimizing adverse effects.
Critical Pitfalls to Avoid
- Do not underdose systemic corticosteroids—underuse is associated with preventable asthma deaths 3, 1
- Do not delay corticosteroid administration—give early in all moderate-to-severe exacerbations 1, 2
- Do not use unnecessarily high doses (>360 mg/day methylprednisolone equivalent)—no additional benefit and increased adverse effects 7, 5
- Do not taper short courses (<7-10 days)—unnecessary and may lead to underdosing during critical recovery period 1, 2
- Do not use IV route routinely—reserve for patients who are vomiting, severely ill, or unable to tolerate oral medications 1, 2, 4
Discharge Planning
- Continue oral prednisolone 30 mg daily or more for 1-3 weeks according to written action plan 2
- Start inhaled corticosteroids at higher dosage than pre-admission at least 48 hours before discharge 2
- Ensure PEF >75% of predicted, diurnal variability <25%, and nocturnal symptoms resolved before discharge 3, 2
- Provide peak flow meter and written instructions for when to escalate treatment 3, 2
- Arrange follow-up with primary care within 1 week and respiratory specialist within 4 weeks 3, 2